evitria is eager to attend the Antibodies as Drugs conference in Breckenridge, USA, from May 05-08. With over 100 approved therapeutic antibodies and engineered formats now comprising 40% of those in clinical development, this conference provides a valuable platform to explore innovative treatments. We look forward to connecting with experts and discussing the translation of fundamental insights into next-generation antibody therapeutics.